CRISPR and Gene Editing: The New Frontier in Fighting Infectious Diseases?
JLabs @ Toronto 661 University Ave Suite 1300, Toronto, Ontario, CanadaPresenters include Karen Gallant, Deputy Executive Director of CARB-X. Few technologies have the potential to disrupt and eliminate infectious disease and viral infections– but gene editing, CRISPR in particular, is […]
The 2019 Canada Gairdner Foundation / Ontario International Symposium: Fuelling the Fight against AMR – Global Innovations in Research & Discovery
McMaster University 1280 Main Street W, Hamilton, Ontario, CanadaKevin Outterson, Executive Director of CARB-X, is participating in a special panel discussion titled "When antibiotics fail: An international conversation about the worrisome evidence of impact and what can be […]
FDA Workshop: Enhancing the Clinical Trial Enterprise for Antibacterial Drug Development in the United States
FDA White Oak Campus - Building 31 10903 New Hampshire Ave, Silver Spring, MD, United StatesPresenters include Kevin Outterson, Executive Director of CARB-X, and Erin Duffy, CARB-X Chief of Research and Development. The FDA, IDSA, NIAID and Pew are co-sponsoring this workshop to focus on […]
Live Webinar: GARDP/REVIVE – Innovation in point-of-care diagnostics for sepsis and bloodstream infections
Webinar 765 Commonwealth Avenue, Boston, MA, United StatesIn this webinar our moderator Caroline Purslow (Nesta Challenges) will welcome three speakers. Till Bachmann (University of Edinburgh) will give an overview of recent advances in AMR diagnostics development. He […]
Exploring Opportunities to Reform Antimicrobial Payment and Post-Market Incentives
Washington Marriott at Metro Center 775 12th Street NW, Washington, DC, United StatesSpeakers include Kevin Outterson, Executive Director of CARB-X. The rise of antimicrobial resistance and the corresponding lack of novel antibiotic development impacts the ability of physicians to provide appropriate care […]
Davos 2020 World Economic Forum – Novo Nordisk Foundation and Novo Holdings: The Broken Model of Antimicrobial resistance
DAVOS-KLOSTERS , SwitzerlandModerator: Kevin Outterson, Executive Director, CARB-X, Professor of Law, Boston University Panel: Lars Rebien Sorensen, Chairman of the Novo Nordisk Foundation and Novo Holdings Jeremy Farrar, Director, Wellcome Trust Dr. Malin […]
Live Webinar: GARDP/REVIVE – Testing for the potential of emergence of antimicrobial resistance
In this webinar, the following aspects will be presented: What are the most common techniques used to measure the extent of the risk of selecting for resistance when using a […]
Live Webinar: GARDP/REVIVE – Non-traditional antibacterial therapeutic options and challenges
Webinar 765 Commonwealth Avenue, Boston, MA, United StatesIn this webinar, the following aspects will be presented: Discovery and early development of “non-traditional” antibacterial approaches is a noticeable trend in the pre-clinical global pipeline These approaches include anti-virulence […]
Live Webinar: GARDP/REVIVE – PK/PD murine infection models: Focus on study elements, variability, and interpretation of results
Webinar 765 Commonwealth Avenue, Boston, MA, United StatesIn this webinar, Alexander J. Lepak will review critical study elements that lead to robust preclinical PK/PD results in the murine model. Topics discussed will include: Understanding and embracing the […]
BAARN2020: Boston Area Antimicrobial Research Network Meeting
Harvard Campus 52 Oxford Street, Cambridge, MA, United StatesThe Boston Area Antimicrobial Resistance Network Meeting, to be held on Friday, March 20th. BAARN2020 will be the 7th iteration of this flagship MSI event, bringing together our collective talents […]